Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cells and cardiovascular disease.

J Dawn Abbott1, Frank J Giordano

  • 1Division of Cardiovascular Medicine, Boyer Center for Molecular Medicine, Yale University School of Medicine, 295 Congress Avenue, New Haven, CT 06520, USA.

Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|August 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis: Two-Year Follow-Up of the AGENT-IDE Randomized Clinical Trial.

Circulation·2026
Same author

The Effect of Restrictive vs Liberal Blood Transfusion Strategy on Subsequent Myocardial Infarction Type.

JACC. Advances·2026
Same author

Reduced-Dose vs Full-Dose Direct Oral Anticoagulants for Extended Anticoagulation Therapy in Patients With Venous Thromboembolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same author

Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT Trial.

Circulation·2026
Same author

Impact of "Door-to-Lactate Clearance" on Clinical Outcomes in Cardiogenic Shock.

JACC. Heart failure·2026
Same author

Cardiogenic Shock Centers and Protocols for Acute Cardiovascular Care: Bridging the Gap Between Spoke and Hub Sites.

Cardiology and therapy·2026
Same journal

AI Will Transform Nuclear Cardiology: Help ASNC Turn Promise into Practice.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2026
Same journal

Clinical Application and Research Advances of PET Molecular Imaging in Immune Checkpoint Inhibitor-Associated Myocarditis.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2026
Same journal

Multimodality Cardiovascular Imaging Reveals Late Recurrence of Cardiac Neoplasm.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2026
Same journal

Immuno-PET in Cardiovascular Disease: Advances, Challenges, and Opportunities.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2026
Same journal

Normal Values for <sup>13</sup>N-Ammonia PET-derived Metrics in Heart Transplant Patients.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2026
Same journal

Corrigendum to "The evolution of Tc-99m-labeled cardiac amyloid radionuclide imaging for transthyretin cardiomyopathy: Current state-of-the-art" [J Nucl Cardiol 59(S) (2026) 102735].

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2026
See all related articles

Adult bone marrow stem cells show potential for regenerating heart muscle and blood vessels, offering new hope for cardiovascular disease treatment. Further research is needed to establish stem cell therapy as a routine clinical practice.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Recent discoveries challenge the notion of no myocardial regeneration potential.
  • Adult bone marrow stem cells exhibit plasticity, differentiating into cardiac myocytes and endothelial cells.

Purpose of the Study:

  • To review the use of adult bone marrow-derived stem cells for ischemic cardiovascular disease.
  • To contrast current progress with future needs for stem cell therapy in cardiology.

Main Methods:

  • Review of animal experiments demonstrating stem cell myogenesis, angiogenesis, and vasculogenesis.
  • Analysis of ongoing human trials and existing literature on stem cell therapy for cardiovascular disease.

Main Results:

Related Experiment Videos

  • Adult stem cells can differentiate into cardiac muscle cells and contribute to new blood vessel formation in the heart.
  • Animal studies show feasibility, leading to human clinical trials.

Conclusions:

  • Stem cell therapy holds promise for replacing lost heart muscle and improving cardiovascular revascularization.
  • Significant questions remain before stem cell therapy becomes standard in cardiovascular medicine.